Tolbutamide sodium

甲苯磺丁钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTolbutamide sodium
Drug Alias Name甲苯磺胺丁钠Orinase diagnostic
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSulfonylurea receptor 1 inhibitors
TargetsSulfonylurea receptor 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1961/06/22
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPharmacia & Upjohn
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacia & Upjohn
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeA10BB03V04CA01
Related LinksWikipediaDrugBankKEGG